Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma.
about
Real world efficacy and safety of ombitasvir, Paritaprevir/r+Dasabuvir+Ribavirin IN genotype 1B patients with HCV liver cirrhosis.Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider.Screening therapeutic targets of ribavirin in hepatocellular carcinoma.
P2860
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Ombitasvir, paritaprevir, rito ...... n of hepatocellular carcinoma.
@ast
Ombitasvir, paritaprevir, rito ...... n of hepatocellular carcinoma.
@en
type
label
Ombitasvir, paritaprevir, rito ...... n of hepatocellular carcinoma.
@ast
Ombitasvir, paritaprevir, rito ...... n of hepatocellular carcinoma.
@en
prefLabel
Ombitasvir, paritaprevir, rito ...... n of hepatocellular carcinoma.
@ast
Ombitasvir, paritaprevir, rito ...... n of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Ombitasvir, paritaprevir, rito ...... n of hepatocellular carcinoma.
@en
P2093
Bojidar Tomov
Deian Jelev
Evelina Atanasova
Krasimir Antonov
Lyudmila Mateva
Nadezhda Zheleva
Tanya Petkova
Yana Boyanova
Zahariy Krastev
P2860
P304
P356
10.3748/WJG.V22.I8.2630
P407
P577
2016-02-01T00:00:00Z